Accenture Seeks Emerging Innovators and Disruptors for Third Annual Accenture HealthTech Innovation Challenge
Call for applications to foster next-generation technology and innovation in the healthcare industry
NEW YORK; July 2, 2018 – Accenture (NYSE: ACN) has kicked off the application period for the third annual
Attracting nearly 1,200 startup applicants in its first two years, the Accenture HealthTech Innovation Challenge – part of Accenture’s broader
Accenture seeks emerging innovators and disruptors for the third annual #HealthTechChallenge
Emerging healthcare technology innovators and disruptors are encouraged to apply for the program by
The three categories for the third annual Accenture HealthTech Innovation Challenge are:
- Keeping a population healthy through wellness and prevention. This category focuses on minimizing hospital visits; wellness/lifestyle management; remote care delivery models; social determinates of health; and better education.
- Using digital health solutions to deliver better patient outcomes. This category focuses on delivering the best outcomes by leveraging digital health solutions, including telehealth; artificial intelligence; digital clinical trials; blockchain; internet of things; drones; digital pills; 3D printing; and real-world evidence.
- Improving healthcare delivery for the patient. This category focuses on healthcare services and efficient healthcare through office/patient management; cost transparency/payments; strategic sourcing; health records; care coordination; and enterprise workflow.
Key criteria that applications should address include solution innovation, solution design quality, disruptive business model, potential impact on patient outcomes, and solution scalability.
Selected finalists will present to an exclusive panel of judges comprising senior executives from globally recognized health and life sciences companies, gaining exposure and access to these industry-leading companies to bring their ideas to market.
Nanowear, manufacturer of a congestive-heart-failure monitoring undergarment and the SimpleSense machine-learning platform, was last year’s HealthTech Innovation Challenge winner. Based in New York City, Nanowear has experienced ongoing success and increased visibility since being named Innovation Champion.
“The Accenture HealthTech Innovation Challenge built significant awareness and momentum for Nanowear as we continue to approach a prominent clinical study and commercial launch later this year,” said Venk Varadan, Nanowear’s co-founder and CEO. “Accenture’s program provided one-of-a-kind connections to more than 50 stakeholders across the very complex healthcare ecosystem, fostering outstanding mentorship opportunities and relationships with providers, payers, device manufacturers, the pharma industry, IT executives, regulatory bodies and healthcare investors. The experience and opportunities are so valuable to a young company like ours, working to solve some of the world’s most challenging healthcare problems.”
Four regional pitching sessions for the competition will take place this year: in Tokyo on Nov. 1; in Sydney on Nov. 15; in Dublin on Nov. 15; and in Boston on Nov. 29.
The final judging round will take place at the
The Accenture HealthTech Innovation Challenge, from Accenture’s
About Accenture
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 449,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025